INFRASTRUCTURE
Our manufacturing network comprises dedicated API and intermediates manufacturing sites engineered to meet stringent international standards and deliver secure, scalable supply.
A cGMP-compliant manufacturing facility producing Synthetic APIs and Bulk Drugs by organic synthesis route. Equipped for stringent global export standards.
Actis is an Intermediates manufacturing site. Actis will remain as Actis for some time and then transition to RPG AP.
API manufacturing site designated as RPG AP – Kamareddy site (in transition to RPG AP).
GLOBAL COMPLIANCE
Our API portfolio is supported by product-specific regulatory documentation, including Applicant’s Part, Restricted Part, ASMFs, DMFs, CEPs, as applicable having regulatory documentation supporting requirements across different global geographies.
Support to Customer for Regulatory Registration, Approvals and Life Cycle Management ensuring business continuity.
Azathioprine
Azathioprine, Risperidone, Mycophenolate Mofetil, Mycophenolate (Process II), Haloperidol, Telmisartan, Amlodipine besilate, Pirfenidone, Ursodeoxycholic acid & Lacosamide
Lercanidipine HCl, Nicorandil, Haloperidol Decanoate
Risperidone, Haloperidol, Haloperidol Decanoate, Sertraline HCl, Lamotrigine, Dapagliflozin propanediol monohydrate
Azathioprine
Nicorandil, Propantheline Bromide
Haloperidol, Azathioprine, Nicorandil
PRODUCT PORTFOLIO
Organized by API Category → API Molecule → Intermediate Details. Click on any molecule tagged with intermediates to view its corresponding chemical intermediates and CAS numbers.
ACTIVE PHARMA INQUIRY
Connect with our Active Pharma experts for enquiries, Commercial Supply and Global Regulatory Support.